AWM Investment Company, Inc. 13D and 13G filings for INVO Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-08 4:34 pm Purchase | 2023-08-31 | 13G | INVO Bioscience, Inc. INVO | AWM Investment Company, Inc. | 63,193 2.600% | 32,000 (+102.59%) | Filing |
| 2023-02-14 1:43 pm Sale | 2022-12-31 | 13G | INVO Bioscience, Inc. INVO | AWM Investment Company, Inc. | 31,193 5.100% | -26,761 (-46.18%) | Filing |
| 2022-02-11 2:58 pm Purchase | 2021-12-31 | 13G | INVO Bioscience, Inc. INVO | AWM Investment Company, Inc. | 57,954 9.900% | 246 (+0.43%) | Filing |
| 2021-05-11 4:08 pm Purchase | 2021-04-30 | 13G | INVO Bioscience, Inc. INVO | AWM Investment Company, Inc. | 57,708 11.100% | 26,458 (+84.66%) | Filing |
| 2021-02-12 11:12 am Purchase | 2020-12-31 | 13G | INVO Bioscience, Inc. INVO | AWM Investment Company, Inc. | 31,250 6.500% | 31,250 (New Position) | Filing |